VBI Vaccines Inc (VBIV)

Sector:
MATERIALS
Industry:
GOLD & SILVER
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Jeff Baxter
Employees:
22
222 THIRD STREET, SUITE 2241, CAMBRIDGE, MA 02142
6178303031

VBI Vaccines, Inc. is a biopharmaceutical company, which develops next generation vaccines to address unmet needs in infectious disease and immuno-oncology. Its products portfolio includes Sci-B-Vac, HBV, CMV Vaccine, GBM Immunotherapy and RSV Vaccine. The company is headquartered in Cambridge, MA.

Data derived from most recent annual or quarterly report
Market Cap 778.265 Million Shares Outstanding256.008 Million Avg 30-day Volume 1.595 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 4.83 / 2.07 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from VBIV instead.

View recent insider trading info

Funds Holding VBIV (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VBIV BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BAIN LINDA

  • Director
0 2021-07-01 2

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
55,042,456 2021-06-29 2

GILLIS STEVEN

  • Director
0 2021-01-27 1

DEWILDE MICHEL

  • Director
0 2021-01-27 1

BAXTER JEFF CEO, PRESIDENT

  • Officer
  • Director
0 2021-01-27 1

ANDERSON DAVID EVANDER CHIEF SCIENTIFIC OFFICER

  • Officer
0 2021-01-27 1

MCKEE BLAINE H.

  • Director
0 2021-01-27 1

MCNULTY CHRISTOPHER CFO AND HEAD OF BD

  • Officer
  • Director
0 2021-01-27 1

DIAZ-MITOMA FRANCISCO CHIEF MEDICAL OFFICER

  • Officer
0 2021-01-27 1

BEATTIE NELL CHIEF BUSINESS OFFICER

  • Officer
0 2021-01-27 1

MAZALTOV AVI HEAD GLOBAL MFG&GM-SCIVAC LTD.

  • Officer
0 2021-01-27 1

CORDEIRO JOANNE

  • Director
0 2021-01-27 1

BRAGA DAMIAN

  • Director
0 2021-01-27 1

ARCH VENTURE FUND VI LP

ARCH VENTURE PARTNERS VI LP

ARCH VENTURE PARTNERS VI LLC

CRANDELL KEITH

BYBEE CLINTON

NELSEN ROBERT

  • 10% Owner
3,397,830 2015-08-17 0

STEINMETZ MICHAEL

  • Director
0 2015-07-30 0

DAVIS TRENT D

  • Director
0 2015-07-30 0

TIMMINS ALAN P

  • Director
0 2015-07-30 0

CHAWLA SAM

  • Director
0 2015-07-30 0

NASCIMENTO EGIDIO CHIEF FINANCIAL OFFICER

  • Officer
0 2015-07-30 0

BUCKLEY T. ADAM VP, BUSINESS DEVELOPMENT

  • Officer
0 2015-07-30 0

KIRCHMEIER MARC VP, VACCINE FORM DEVELOPMENT

  • Officer
0 2015-07-30 0

PAULSON CHARLES

  • SEE EXPLANATORY NOTE BELOW
No longer subject to file 2014-07-25 0

SHOEN PAUL F

  • SEE EXPLANATORY NOTE BELOW
No longer subject to file 2014-07-25 0

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

  • 10% Owner
2,270,404 2014-07-25 0

CLARUS LIFESCIENCES I, L.P.

  • 10% Owner
4,973,820 2014-07-25 0

SMITH MURRAY GEORGE

  • SEE EXPLANATORY NOTE BELOW
No longer subject to file 2014-07-25 0

PRATT SHANNON

  • Director
271,054 2014-04-10 0

PAULSON CHESTER L F

  • 10% Owner
1,435,514 2014-03-19 0

ERICSON NILS ALEXANDER

  • SEE FOOTNOTE (1)
0 2010-03-16 0

JAMESON ISAAC W

  • SEE REMARKS
No longer subject to file 2010-02-19 0

MCCHESNEY SHAWN

  • SEE FOOTNOTE (1)
0 2009-10-13 0

PAULSON CHESTER L F CHAIRMAN

PAULSON JACQUELINE M CORPORATE SECRETARY/TREASURER

  • Officer
  • Director
  • 10% Owner
2,971,284 2009-09-15 0

MAXFIELD MARGARET L

  • SEE FOOTNOTE (1)
0 2009-07-01 0

RICE CAROL A

  • SEE FOOTNOTE (1)
0 2009-07-01 0

JAMES BARBARA

  • SEE FOOTNOTE (1)
0 2009-07-01 0

JOHANNES KAREN CHIEF FINANCIAL OFFICER

  • Officer
  • SEE FOOTNOTE (1)
0 2009-07-01 0

PAULSON ERICK

  • SEE FOOTNOTE (1)
0 2009-07-01 0

SCHREIBER CHRISTOPHER

  • SEE FOOTNOTE (1)
0 2009-07-01 0

STRIPLIN HARRY L

  • SEE FOOTNOTE (1)
No longer subject to file 2008-04-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VBI VACCINES INC VBIV 2021-10-26 19:15:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 18:45:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 18:15:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 17:45:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 17:15:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 16:45:04 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 16:15:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 15:45:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 15:15:03 UTC -0.5481 0.6181 2900000
VBI VACCINES INC VBIV 2021-10-26 14:45:03 UTC -0.5482 0.6182 2900000
VBI VACCINES INC VBIV 2021-10-26 14:15:05 UTC -0.5482 0.6182 2900000
VBI VACCINES INC VBIV 2021-10-26 13:45:03 UTC -0.5482 0.6182 2900000
VBI VACCINES INC VBIV 2021-10-26 13:15:03 UTC -0.5482 0.6182 2900000
VBI VACCINES INC VBIV 2021-10-26 12:45:03 UTC -0.5482 0.6182 2900000
VBI VACCINES INC VBIV 2021-10-25 22:15:03 UTC -0.5482 0.6182 3100000
VBI VACCINES INC VBIV 2021-10-25 21:45:03 UTC -0.5482 0.6182 3100000
VBI VACCINES INC VBIV 2021-10-25 21:15:03 UTC -0.5482 0.6182 3100000
VBI VACCINES INC VBIV 2021-10-25 20:45:03 UTC -0.5482 0.6182 3100000
VBI VACCINES INC VBIV 2021-10-25 20:15:03 UTC -0.5482 0.6182 3100000
VBI VACCINES INC VBIV 2021-10-25 19:45:04 UTC -0.5482 0.6182 3100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments